Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial

Beatrice A. Chen, Lori Panther, Mark A. Marzinke, Craig W. Hendrix, Craig J. Hoesley, Ariane van der Straten, Marla J. Husnik, Lydia Soto-Torres, Annalene Nel, Sherri Johnson, Nicola Richardson-Harman, Lorna K. Rabe, Charlene S. Dezzutti, Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized Trial. Journal of Acquired Immune Deficiency Syndromes. ,vol. 70, pp. 242- 249 ,(2015) , 10.1097/QAI.0000000000000702

Rochelle K. Rosen, Jacob J. van den Berg, Sara E. Vargas, Natali Senocak, Julia G. Shaw, Robert W. Buckheit, Kelley Alison Smith, Kate Morrow Guthrie, Meaning-making matters in product design: users’ sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings Contraception. ,vol. 92, pp. 596- 601 ,(2015) , 10.1016/J.CONTRACEPTION.2015.08.007

Sheena McCormack, David T Dunn, Monica Desai, David I Dolling, Mitzy Gafos, Richard Gilson, Ann K Sullivan, Amanda Clarke, Iain Reeves, Gabriel Schembri, Nicola Mackie, Christine Bowman, Charles J Lacey, Vanessa Apea, Michael Brady, Julie Fox, Stephen Taylor, Simone Antonucci, Saye H Khoo, James Rooney, Anthony Nardone, Martin Fisher, Alan McOwan, Andrew N Phillips, Anne M Johnson, Brian Gazzard, Owen N Gill, Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial The Lancet. ,vol. 387, pp. 53- 60 ,(2016) , 10.1016/S0140-6736(15)00056-2

L Bélec, D Meillet, M Lévy, A Georges, C Tévi-Bénissan, J Pillot, Dilution assessment of cervicovaginal secretions obtained by vaginal washing for immunological assays. Clinical and Vaccine Immunology. ,vol. 2, pp. 57- 61 ,(1995) , 10.1128/CDLI.2.1.57-61.1995

R P Nugent, M A Krohn, S L Hillier, Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. Journal of Clinical Microbiology. ,vol. 29, pp. 297- 301 ,(1991) , 10.1128/JCM.29.2.297-301.1991

Craig W. Hendrix, Adriana Andrade, Namandjé N. Bumpus, Angela D. Kashuba, Mark A. Marzinke, Ayana Moore, Peter L. Anderson, Lane R. Bushman, Edward J. Fuchs, Ilene Wiggins, Christine Radebaugh, Heather A. Prince, Rahul P. Bakshi, Ruili Wang, Paul Richardson, Eugenie Shieh, Laura McKinstry, Xin Li, Deborah Donnell, Vanessa Elharrar, Kenneth H. Mayer, Kristine B. Patterson, Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066) AIDS Research and Human Retroviruses. ,vol. 32, pp. 32- 43 ,(2016) , 10.1089/AID.2015.0182

Marc M. Baum, Irina Butkyavichene, Scott A. Churchman, Gilbert Lopez, Christine S. Miller, Thomas J. Smith, John A. Moss, An intravaginal ring for the sustained delivery of tenofovir disoproxil fumarate. International Journal of Pharmaceutics. ,vol. 495, pp. 579- 587 ,(2015) , 10.1016/J.IJPHARM.2015.09.028

Cynthia Woodsong, Jonathon D.S. Holt, Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancy Advanced Drug Delivery Reviews. ,vol. 92, pp. 146- 154 ,(2015) , 10.1016/J.ADDR.2015.02.004

K. Rivet Amico, Leila E. Mansoor, Amy Corneli, Kristine Torjesen, Ariane van der Straten, Adherence Support Approaches in Biomedical HIV Prevention Trials: Experiences, Insights and Future Directions from Four Multisite Prevention Trials Aids and Behavior. ,vol. 17, pp. 2143- 2155 ,(2013) , 10.1007/S10461-013-0429-9

W. Kruse, W. Eggert-Kruse, J. Rampmaier, B. Runnebaum, E. Weber, Dosage frequency and drug-compliance behaviour--a comparative study on compliance with a medication to be taken twice or four times daily. European Journal of Clinical Pharmacology. ,vol. 41, pp. 589- 592 ,(1991) , 10.1007/BF00314990